Crossmark

Nonadditivity in public and inhouse data: implications for drug design

Published Online: 2021-07-02

Published Print: 2021-12

Authors

Gogishvili, D.

Nittinger, E. http://orcid.org/0000-0001-7231-7996
Margreitter, C.

Tyrchan, C.
License Information

Text and Data Mining valid from 2021-07-02

Version of Record valid from 2021-07-02
More Information

Article History

Received: 10 December 2020

Accepted: 9 June 2021

First Online: 2 July 2021

Declarations

:

: The authors declare that they have no competing interests. CM, CT and EN are employees of AstraZeneca and own stock options.

Document is current